Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
March 23, 2021 at 06:34 pm EDT
Share
Universal Vision Biotechnology Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 2,053.141 million compared to TWD 1,418.979 million a year ago. Operating income was TWD 596.515 million compared to TWD 247.043 million a year ago. Net income was TWD 483.214 million compared to TWD 238.005 million a year ago. Basic earnings per share was TWD 6.35 compared to TWD 3.13 a year ago. Diluted earnings per share was TWD 6.34 compared to TWD 3.12 a year ago.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. 
